Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 151 Carcinoma, Non-Small-Cell Lung 96 Lung Neoplasms 50 Hodgkin Disease 22 Lymphoma 15 Recurrence 14 Neoplasm Metastasis 14 Triple Negative Breast Neoplasms 12 Neoplasms 12 Prostatic Neoplasms 10 Sarcoma 8 Lymphoma, Non-Hodgkin 8 Uterine Cervical Neoplasms 7 Rhabdomyosarcoma 7 Adenocarcinoma of Lung 7 Lymphoma, Large B-Cell, Diffuse 6 Ovarian Neoplasms 5 Mesothelioma, Malignant 5 Breast Neoplasms, Male 5 Small Cell Lung Carcinoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 NSCLC 4 Brain Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Multiple Myeloma 3 Mesothelioma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

Cisplatin 223 Radiotherapy 158 Cetuximab 123 pembrolizumab 103 Fluorouracil 84 Docetaxel 82 Paclitaxel 72 Carboplatin 69 Radiotherapy, Intensity-Modulated 62 Nivolumab 34 Radiation 28 Drug Therapy 26 Gemcitabine 23 Erlotinib Hydrochloride 20 Gefitinib 19 Standard of Care 18 durvalumab 17 Surveys and Questionnaires 17 Surgical Procedures, Operative 17 Pemetrexed 17 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 atezolizumab 15 Capecitabine 15 Everolimus 14 Bevacizumab 14 Amifostine 14 Radiosurgery 13 Low-Level Light Therapy 13 Immunohistochemistry 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01020864 2020-11-02

CECAVI

Odense University Hospital

Phase 2 Withdrawn

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡